Benutzer: Gast  Login
Titel:

Should belatacept be the centrepiece of renal transplantation?

Dokumenttyp:
Journal Article; Review; Review
Autor(en):
Huber, Monika; Kemmner, Stephan; Renders, Lutz; Heemann, Uwe
Abstract:
Belatacept was developed to minimize cardiovascular risk and nephrotoxicity associated with calcineurin inhibitor (CNI)-based immunosuppression. Recently, 7-year data from the Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT), a phase III study comparing belatacept with cyclosporine, have been published. While during the first year of belatacept the risk of acute rejection episodes was elevated, this seemingly had marginal consequences for lon...     »
Zeitschriftentitel:
Nephrol Dial Transplant
Jahr:
2016
Band / Volume:
31
Heft / Issue:
12
Seitenangaben Beitrag:
1995-2002
Sprache:
eng
Volltext / DOI:
doi:10.1093/ndt/gfw226
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/27288461
Print-ISSN:
0931-0509
TUM Einrichtung:
Fachgebiet Nephrologie (Prof. Heemann)
 BibTeX